Drug trials for experimental Ebola drug, ZMapp have begun in Liberia, authorities say.
US, Liberia begin ZMapp drug trials
The trial is a joint effort between the Liberian government and the US National Institute of Allergy and Infectious Diseases (NIAID).
Recommended articles
Adults and children infected with Ebola will participate in the trial which will also be conducted in the US.
The drug was created by Mapp Biopharmaceutical Inc's and has already been used in treating a few Ebola patients, including two US aid workers.
However, according to the Director of the NIAID, Anthony Fauci there’s still no way to tell if ZMapp is safe and effective in treating the disease.
ADVERTISEMENT
The trial is expected to conclude in December 2016, subject to changes in the current epidemic.
Ebola has killed more than 9,000 people in West Africa in the current outbreak which has been described as the worst in history.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
Anambra residents pour encomium on retiring CP Adeoye
Gov Zulum approves employment of 15 persons with disabilities
4 dead, 70 vehicles burnt in fuel tanker explosion in Rivers
You can't artificially force naira to gain value, Ned Nwoko tells CBN, FG
19 children feared killed by measles complications in Adamawa
Niger Delta youths urge stakeholders to support amnesty program boss Otuaro
Dufil Prima Foods brings relief to indigent families in Abeokuta
World Bank anticipates substantial decline in global food prices by 2025
Yahaya Bello's nemesis, Akpoti tells EFCC to see ex-governor's case to the end
ADVERTISEMENT
![FCE, Zaria sets committee to investigate 12 students suspected to be cultists [myschoolgist]](data:image/svg+xml;charset=utf8,%3Csvg%20xmlns%3D'http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg'%20width%3D'300'%20height%3D'172'%20data-ring-placeholder%3D'1'%3E%3C%2Fsvg%3E "FCE, Zaria sets committee to investigate 12 students suspected to be cultists [myschoolgist]")